Celltrion
Clinical trials sponsored by Celltrion, explained in plain language.
-
New combo pill tested to tame stubborn high blood pressure
Disease control CompletedThis study tested whether combining two common blood pressure medications (AZM and AML) works better than taking either drug alone. It involved 890 adults whose high blood pressure wasn't well controlled on one of these medications. Participants were randomly assigned to take the…
Phase: PHASE3 • Sponsor: Celltrion • Aim: Disease control
Last updated Apr 04, 2026 02:06 UTC
-
Drug delivery showdown: pen vs. syringe
Knowledge-focused CompletedThis study tested whether a biosimilar drug (CT-P43, similar to Stelara) works the same way in the body when given by an auto-injector pen versus a traditional pre-filled syringe. It involved 162 healthy male volunteers to compare how the body absorbs the drug and to check for sa…
Phase: PHASE1 • Sponsor: Celltrion • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Scientists test how new diabetes drugs move through healthy bodies
Knowledge-focused CompletedThis early-stage study aimed to understand how the body processes and tolerates new drug combinations for Type 2 diabetes. It involved 49 healthy volunteers who received single doses of the drugs. The main goal was to measure drug levels in the blood and check for safety, not to …
Phase: PHASE1 • Sponsor: Celltrion • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Early safety testing begins for new drug combinations
Knowledge-focused CompletedThis early-stage study tested the safety and how the body processes two different drug combinations in healthy volunteers. Forty participants received either a combination of two drugs (CTL0201 and CTL0202) or a single drug (CT-L02) in a crossover design. Researchers measured dru…
Phase: PHASE1 • Sponsor: Celltrion • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC